solute carrier family 25 member 15
آخر تحديث 18 Aug 2020
يتوافق مع الإرشادات التحريرية
- تنزيلتنزيل
- مشاركة
- Language
- نقاش
- Ask Patient
- نسخة صوتية
- أضف إلى المصادر المفضلة على جوجل
ال SLC25A15 gene provides instructions for making a protein called mitochondrial ornithine transporter 1. This protein participates in the urea cycle, which is a sequence of biochemical reactions that occurs in liver cells. The urea cycle breaks down excess nitrogen, made when protein is broken down by the body, to make a compound called urea that is excreted by the kidneys in urine. Excreting the excess nitrogen prevents it from accumulating in the form of ammonia, which is toxic, especially to the nervous system.
اختيارات الفيديو لـ Genesمكتبة الفيديو
Normal function
ال SLC25A15 gene provides instructions for making a protein called mitochondrial ornithine transporter 1. This protein participates in the urea cycle, which is a sequence of biochemical reactions that occurs in liver cells. The urea cycle breaks down excess nitrogen, made when protein is broken down by the body, to make a compound called urea that is excreted by the kidneys in urine. Excreting the excess nitrogen prevents it from accumulating in the form of ammonia, which is toxic, especially to the nervous system.
Mitochondrial ornithine transporter 1 is needed to move a molecule called ornithine within the mitochondria (the energy-producing centers in cells). Specifically, this protein transports ornithine across the inner membrane of mitochondria to the region called the mitochondrial matrix, where it participates in the urea cycle.
Conditions referring to this gene or chromosome
Other names
D13S327
HHH
ORC1
ornithine transporter 1
ORNT1
ORNT1_HUMAN
OTTHUMP00000042249
solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15
Related patient information and medicines

Patient information leaflet
التليف الكيسي
What causes cystic fibrosis. Cystic fibrosis is a genetic disorder. A genetic disorder is one that can be passed on from your parents through your genes. This ... If you inherit only one cystic fibrosis gene, you are called a carrier. About 1 in 25 people in the UK of white European descent يكون carriers of the cystic fibrosis gene. It is much less.

Patient information leaflet
داء ترسب الأصبغة الدموية
Find out more here: [/health/haemochromatosis-leaflet](https://patient.info/health/haemochromatosis-leaflet) People with haemochromatosis have inherited a faulty gene, which directs the body to absorb too much iron from what they eat and drink. Causes of haemochromatosis Haemochromatosis هو a genetic condition. Approximately 1.

Patient information leaflet
التخطيط للحمل
Screening tests Pregn... Some women may wish to have the screening test before becoming pregnant, especially if their family origins make these diseases more likely. People from families originating from Africa, the Caribbean, Southeast Asia, Sardinia, Greece, Turkey or Cyprus are more likely to have one of these conditions or to be a carrier for.

Patient information leaflet
مرض الكلى المتعدد الكيسات
This means that one or more of your genes is faulty, which results in you making many cysts in the kidneys. There are different types of polycystic kidney disease: Autosomal dominant polycystic kidney disease (ADPKD) This is the most common type. This is an hereditary condition caused by a faulty gene which is inherited from one parent. Although.

Patient information leaflet
تكور الدم الوراثي
Hereditary spherocytosis (HS) هو an inherited condition of red blood cells. The disease can be mild and go unrecognised in some people. In others there may be severe anaemia requiring regular blood transfusions. Some people with hereditary spherocytosis may be offered surgery to remove their spleen. This usually helps the condition, but increases.

Patient information leaflet
مرض ويلسون
When the copper storage capacity of the liver cells is exhausted, the copper spills into the bloodstream and deposits copper in other parts of the body, mainly the brain. How is Wilson's disease inherited. مرض ويلسون هو an autosomal recessive disorder. This means that, in order to develop Wilson's disease, two abnormal ATP7B genes must be.
قراءة إضافية ومراجع
- solute carrier family 25 member 15; MedlinePlus, National Library of Medicine.
- Camacho JA, Mardach R, Rioseco-Camacho N, Ruiz-Pesini E, Derbeneva O, Andrade D, Zaldivar F, Qu Y, Cederbaum SD. Clinical and functional characterization of a human ORNT1 mutation (T32R) in the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome. Pediatr Res. 2006 Oct;60(4):423-9. doi: 10.1203/01.pdr.0000238301.25938.f5. Epub 2006 Aug 28.
- Camacho JA, Obie C, Biery B, Goodman BK, Hu CA, Almashanu S, Steel G, Casey R, Lambert M, Mitchell GA, Valle D. Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome is caused by mutations in a gene encoding a mitochondrial ornithine transporter. Nat Genet. 1999 Jun;22(2):151-8. doi: 10.1038/9658.
- Camacho JA, Rioseco-Camacho N, Andrade D, Porter J, Kong J. Cloning and characterization of human ORNT2: a second mitochondrial ornithine transporter that can rescue a defective ORNT1 in patients with the hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, a urea cycle disorder. Mol Genet Metab. 2003 Aug;79(4):257-71. doi: 10.1016/s1096-7192(03)00105-7.
- Martinelli D, Diodato D, Ponzi E, Monne M, Boenzi S, Bertini E, Fiermonte G, Dionisi-Vici C. The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome. Orphanet J Rare Dis. 2015 Mar 11;10:29. doi: 10.1186/s13023-015-0242-9.
- Miyamoto T, Kanazawa N, Kato S, Kawakami M, Inoue Y, Kuhara T, Inoue T, Takeshita K, Tsujino S. Diagnosis of Japanese patients with HHH syndrome by molecular genetic analysis: a common mutation, R179X. J Hum Genet. 2001;46(5):260-2. doi: 10.1007/s100380170075.
- Palmieri F. The mitochondrial transporter family (SLC25): physiological and pathological implications. Pflugers Arch. 2004 Feb;447(5):689-709. doi: 10.1007/s00424-003-1099-7. Epub 2003 Nov 4.
- Waisbren SE, Gropman AL; Members of the Urea Cycle Disorders Consortium (UCDC); Batshaw ML. Improving long term outcomes in urea cycle disorders-report from the Urea Cycle Disorders Consortium. J Inherit Metab Dis. 2016 Jul;39(4):573-84. doi: 10.1007/s10545-016-9942-0. Epub 2016 May 23.
تاريخ المقال
المقال متاح أيضًا باللغة الإنجليزية, الألمانية, إسبانية, الفرنسية, إيطالي, البرتغالية, الهندية, العبرية, العربية ,، و السويدية.
18 Aug 2020 | أحدث إصدار
1 أغسطس 2019 | نُشر في الأصل
شارك أفكارك أو تجاربك مع الآخرين في مجتمعات المرضى.
اشترك في النشرة الإخبارية للمرضى
جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.
من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.

